A new assay to screen for head and neck squamous cell carcinoma using the tumor marker metallopanstimulin

Otolaryngology - Head and Neck Surgery

Volumn 131, Issue 4, 2004, Pages 466-471

  Lee, Wha Joon ^a   Keefer, K ^a   Hollenbeak, C S ^b   Stack Jr , B C ^a,b  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^b PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR MARKER;

ARTICLE; BLOOD BANK; BLOOD DONOR; CANCER SCREENING; CONTROLLED STUDY; DENSITOMETRY; HEAD AND NECK CARCINOMA; HUMAN; IMMUNOPRECIPITATION; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; RADIOIMMUNOASSAY; SEROLOGY; SERUM; SLOT BLOT HYBRIDIZATION; STATISTICAL SIGNIFICANCE; VOLUNTEER; WESTERN BLOTTING;

BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HEAD AND NECK NEOPLASMS; HUMANS; METALLOPROTEINS; NUCLEAR PROTEINS; PRECIPITIN TESTS; RIBOSOMAL PROTEINS; RNA-BINDING PROTEINS; TUMOR MARKERS, BIOLOGICAL;

EID: 4644365755     PISSN: 01945998     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.otohns.2004.03.011     Document Type: Article

References (20)

1. Jemal A., Thomas A., Murray T., et al. Cancer statistics, 2002. CA Cancer J Clin. 52:2002;23-47
2. Million RR, Cassisi NJ, eds. Management of head and neck cancer. 2nd ed. Philadelphia: Williams and Wilkins; 1993. p. 75-142
3. de Visscher A.V., Manni J.J. Routine long-term follow-up in patients treated with curative intent for squamous cell carcinoma of the larynx pharynx and oral cavity. Does it make sense? Arch Otolaryngol Head Neck Surg. 120:1994;934-939
4. Boysen M., Lovdal O., Tausjo J., et al. The value of follow-up in patients treated for squamous cell carcinoma of the head and neck. Eur J Cancer. 28:1992;426-430
5. Marchant F.E., Lowry L.D., Moffitt J.J., et al. Current national trends in the posttreatment follow-up of patients with squamous cell carcinoma of the head and neck. Am J Otolaryngol. 14:1993;88-93
6. Mashberg A., Samit A. Early diagnosis of asymptomatic oral and oropharyngeal squamous cancers. CA Cancer J Clin. 45:1995;328-351
7. Ropka M.E., Goodwin W.J., Levine P.A., et al. Effective head and neck tumor markers the continuing quest. Arch Otolaryngol Head Neck Surg. 117:1991;1011-1014
8. Walther E.K., Dahlmann N., Gorgulla H.T. Tumor markers in the diagnosis and follow-up of head and neck cancer role of CEA, CA19-9, SCC, TK, and DTTPASE. Head Neck. 15:1993;230-235
9. Boyle J.O., Hakim J., Koch W.M., et al. The incidence of p53 mutation increases with progression of head and neck cancer. Molecular assessment of histopathologic staging in squamous cell carcinoma of the head and neck. Cancer Res. 53:1993;4477-4480
10. Berg J.M., Shi Y. The galvanization of biology a growing appreciation for the roles of zinc. Science. 271:(5252):1996;1081-1085
11. Berg J.M. Zinc finger domains hypotheses and current knowledge. Annu Rev Biophys Biophys Chem. 19:1990;405-421
12. Fernandez-Pol J.A., Hamilton P.D., Klos D.J. Essential viral and cellular zinc and iron containing metalloproteins as targets for novel antiviral and anticancer agents implications for prevention and therapy of viral diseases and cancer. Anticancer Res. 21:2001;931-957
13. Stack B.C. Jr, Dalsaso T.A., Lee C., et al. Overexpression of MPS antigens by squamous cell carcinomas of the head and neck immunohistochemical and serological correlation with FDG positron emission tomography. Anticancer Res. 19:1999;5503-5510
14. Fernandez-Pol J.A., Klos D.J., Hamilton P.D. Metallopanstimulin gene product produced in a baculovirus expression system is a nuclear phosphoprotein that binds to DNA. Cell Growth Differ. 5:1994;811-825
15. Fernandez-Pol J.A. Metallopanstimulin as a novel tumor marker in sera of patients with various types of common cancers implications for prevention and therapy. Anticancer Res. 16:(4B):1996;2177-2185
16. Fernandez-Pol J.A., Klos D.J., Hamilton P.D. A growth factor-inducible gene encodes a novel nuclear protein with zinc finger structure. J Biol Chem. 268:1993;21198-21204
17. DeVita VT, Hellman S, Rosenburg SA. Cancer: principles and practice of oncology; 1997
18. Wool I.G. Extraribosomal functions of ribosomal proteins. Trends Biochem Sci. 21:1996;164-165
19. Chan Y.L., Olvera J., Paz V., et al. The primary structures of rat ribosomal proteins S3a (the V-Fos transformation effector) and of S3b. Biochem Biophys Res Commun. 228:1996;141-147
20. Hollenbeak C.S., Schvidler J., Keefer K., et al. The value of MPS, p53, and uPA as serum tumor markers for head and neck cancer. Mohan R.M. Research advances in cancer. vol. 3:2003;Global Research Network, Kerala, India